SHH PATHWAY SENSOR · Interpreting the SHH signal: real-time monitoring of the dynamic regulation of GLI3
FP7 — People (Marie Curie Actions)
- Duration
- 2009-10-01 → 2012-09-30
- EU contribution
- €45,000
- Participants
- 1
- Scheme
- MC-ERG
Lines connect the coordinator with its partners.
Results in brief
Interpreting the SHH signal: real-time monitoring of the dynamic regulation of GLI3
The Hedgehog signalling pathway plays a critical role during the development of the vertebrate embryo. Amongst other structures, the SHH secreted protein is involved in formation of the limb skeleton, and loss of SHH activity leads to severe limb truncations both in human and mouse. Depending if a cell is exposed or not to the SHH signal, the profile of expressed genes changes, and such modulation of the cellular response to SHH depends on the GLI transcriptional regulators. Therefore, we set out to characterise those genes that are directly regulated by GLI proteins during limb organogenesis. In particular, we were interested in the role of GLI3 during limb bud development, as its deficiency results in aberrant activation of Hedgehog signal transduction and polydactyly (appearance of extra digits), both in mouse and humans. To do so, I developed a series of mouse genetic tools that would allow us to: 1) detect the endogenous GLI3 protein isoforms with high sensitivity; 2) inactivate the Gli3 gene in a spatio-temporal controlled manner. By using a combination of genetic, molecular, and cellular assays, we discovered that GLI3 curbs the proliferation of limb bud mesenchymal progenitors by directly regulating the cell cycle. In particular, the endogenous GLI3 proteins interact with the cis-regulatory region controlling Cdk6 expression. In addition, GLI3 also directly regulates Grem1 expression, a secreted antagonist of BMP activity, which regulates the formation of the cartilage elements prefiguring the limb skeleton. Our genetic analysis revealed that GLI3 is an essential gatekeeper that controls both the proliferative expansion of progenitors and assures their timely differentiation into chondrocytes. In other words, in the absence of Gli3, the progenitors giving rise to the digits (= fingers) do not know when to exit proliferation and start to form the cartilage elements. This explains why inactivation of Gli3 results in production of too many cells and ultimately the formation of extra fingers and toes. Therefore, Gli3 is a critical component in the molecular networks that restrict digit number to five. As mutations affecting the human GLI3 gene also result in to polydactyly (such as in the Greig's cephalopolysyndactyly and Pallister-Hall syndromes), it is likely that alterations of the cell cycle and/or the onset of cartilage differentiation underlie the variable polydactylies observed in human congenital limb malformations. Our research has been focused on the functions of GLI3/SHH target genes during embryonic limb development, but our study is likely of relevance for other biological systems depending on the Hedgehog pathway, such as maintenance of adult stem cells and malignant progression of certain types of tumours such as medulloblastoma (one of the deadliest childhood cancers) or basal cell carcinomas. For instance, some of the direct GLI3 target genes we know to regulate cell proliferation are potential therapeutic targets for interfering with cancer cell proliferation (such as e.g. Cdk6). Furthermore, the epitope tag we have inserted into the endogenous GLI3 protein has enabled us to identify direct targets of SHH signalling and the relevant cis-regulatory regions in both wild-type and different mutant contexts using both candidate genes and genome-wide approaches. This is an important tool for gaining insight into how cells integrate SHH signalling inputs into a transcriptional response that e.g. controls the balance of proliferation and differentiation of limb bud mesenchymal progenitor cells.
Data: CORDIS, © European Union
Project objective
The SHH morphogenetic pathway exerts multiple functions during embryonic and adult life. It is involved in various cellular contexts to provide positional information, but also controls cell survival, proliferation and differentiation. Aberrant activation of the pathway has also been linked to tumour formation and growth. The SHH signal is integrated by receiving cells via the GLI transcription factors, which regulate the expression of SHH target genes. In particular, the GLI3 protein is processed into a repressor (GLI3R) form in the absence of SHH, while is converted into a transcriptional activator (GLI3A) upon exposure to SHH. SHH being a secreted factor, it is thought to establish a dual GLI3R:GLI3A gradient, with high levels of the GLI3R away from the source and high GLI3A close to the SHH-expressing cells. This mechanism permits various levels of activation of the pathway, depending on the GLI3R:GLI3A ratio. Despite the initial description of many pathway target genes, the primary response to variable SHH doses over time, and the subsequent alterations in GLI3R:GLI3A isoform ratios, are poorly understood. We have manipulated the Gli3 locus in mouse ES cells by RMCE to introduce a FLAG-tag into the endogenous protein. We have evidence that this FLAG-tagged GLI3 creates a sensor of the SHH signal (GLI3A-FLAG). We will use neuralized embryoid bodies and the knock-in mouse line derived from GLI3A-FLAG ES cells to monitor the cellular and molecular dynamics of GLI3A in sensing SHH activity. This system will permit us to track the relative occupancy of the promoter/regulatory elements of SHH target genes by GLI3, allowing a real-time readout of the way cells respond to SHH over time. Moreover, we will be able to visualize and study the postulated Gli3A gradient in vivo. Funding from the ERG program, together with the long-term contract I have been offered, would be a significant asset in establishing myself as an independent reseacher.
Original text from CORDIS.
Participants
- UNIVERSITAT BASEL · BaselCoordinatorSwitzerland
Links
Data: CORDIS, © European Union
